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Photolyase/cryptochrome blue-light photoreceptors are mono-
meric proteins of 50–70 kDa that contain two non-covalently bound
chromophore/cofactors (1, 2). One of the cofactors is always FAD.
The second chromophore is methenyltetrahydrofolate (MTHF)1 in
most organisms and 8-hydroxy-5-deazariboflavin in a few species
that synthesize this cofactor. Photolyase repairs UV-induced DNA
damage using violet/blue light (350–500 nm) as the energy source
to initiate the reaction. Cryptochrome, which exhibits up to 50%
sequence identity to some photolyases (3), regulates some of the
blue-light responses including growth and development in plants
and the circadian rhythm by light-independent and light-depend-
ent mechanisms in animals (4, 5). Circadian rhythm is the oscilla-
tion in the biochemical, physiological, and behavioral functions of
organisms with a periodicity of about 1 day (circa  about, dies 
day). The innate rhythm is never precisely 24 h. However, it is
synchronized to the 24-h solar day with light input from the environ-
ment. This light-induced synchronization (entrainment) maintains
the diurnal (day dwelling) and nocturnal (night dwelling) organisms
active only in their particular temporal habitats and is presumed to
confer selective advantage (4).
The molecular mechanism of DNA repair by photolyase is known
in considerable detail (2). In contrast, there is, at present, no
information on the photochemical reaction carried out by crypto-
chrome. The structure-function of photolyase will be briefly re-
viewed to provide a mechanistic background for how cryptochrome
may work. Our current understanding of the mammalian crypto-
chrome structure-function will then be summarized.
Structure and Function of Photolyase
UV light (200–300 nm) induces two major lesions in DNA, the
cyclobutane pyrimidine dimer (PyrPyr) and the pyrimidine-
pyrimidone (6–4) photoproduct. Photolyases repair these lesions
by using 350–500-nm photons as a second substrate or cofactor.
Photolyases that repair PyrPyr and (6–4) photoproducts are
evolutionarily related but functionally distinct. Thus, a given pho-
tolyase may repair either PyrPyr or the (6–4) photoproduct,
and accordingly the enzymes have been classified as cyclobutane
pyrimidine photolyase and (6–4) photolyase (3). Photolyase with-
out further qualification means cyclobutane pyrimidine photolyase,
and it will be used as such in this review. Photolyase has been
found in many species from all three kingdoms of life, but similarly
some species from all three kingdoms lack the enzyme (see Refs. 2
and 3).
Crystal structures of photolyases from Escherichia coli (6) and
Anacystis nidulans (7) have been determined. The crystal structure
of E. coli photolyase will be summarized as representative of this
family of proteins (Fig. 1). The enzyme is composed of two domains:
an N-terminal / domain (residues 1–131) and a C-terminal -hel-
ical domain (residues 204–471), which are connected to one an-
other with a long loop that wraps around the / domain. The
MTHF photoantenna is bound in a shallow cleft between the two
domains, and the FAD cofactor is deeply buried within the -helical
domain. A surface potential representation of the molecule reveals
a positively charged groove running the length of the molecule. A
hole in the middle of this groove leads to the flavin in the core of the
-helical domain.
Photolyase recognizes the 30° kink caused in DNA by PyrPyr
(8, 9); then, it “flips out” the dimer from within the duplex to the
active site cavity of the enzyme to form a high stability complex.
Light initiates catalysis (Fig. 2); the MTHF photoantenna absorbs
a photon and transfers the energy to FADH (the active form of
flavin in photolyase) by Förster resonance energy transfer. The
excited state flavin, 1(FADH)*, transfers an electron to PyrPyr
to generate a charge-separated radical pair (FADH° . . .
PyrPyr°). The cyclobutane ring is split by (s
2  s
2) cyclorever-
sion, and the flavin radical is restored to the catalytically competent
FADH form by back electron transfer following splitting of the
cyclobutane ring. The repaired dinucleotide no longer fits in the
active site pocket and is ejected back into the duplex, and the re-
paired DNA dissociates from the enzyme. It is thought that the (6–4)
photolyase employs essentially the same mechanism as classical
photolyase (10, 11).
Cryptochromes
For over 125 years it has been known that blue light elicits
several responses in plants including phototropism, photoperio-
dism (measuring day length), and growth and development (12).
The nature of the blue-light receptor remained cryptic for a long
time and the term “cryptochrome” was coined to refer to this
mysterious pigment responsible for blue light responses (13). Now
it is known that plants contain at least three types of flavoproteins
that would fit the original definition of cryptochrome: phototropin
(14), FKF1 (15), and the protein that is encoded by the HY4 gene of
Arabidopsis thaliana that exhibits high similarity to DNA photol-
yase (16). The HY4-encoded blue-light photoreceptor was the first
putative plant blue-light photoreceptor discovered and hence it was
assumed to be the elusive “cryptochrome” and was renamed as such
(17). Now, by convention any protein in plants, animals, or bacteria
with similarity to photolyase and with no repair function is called
a cryptochrome and is presumed to perform a blue-light receptor
function (1–5). Cryptochromes exhibit 25–50% sequence identity to
photolyase (18) and, like photolyases, contain both FAD and folate
as cofactors (17, 19). Most cryptochromes, including the human
cryptochromes, have C-terminal extensions of 20–200 amino acids
beyond the photolyase homology region. Of all cryptochromes
identified to date, the Arabidopsis cryptochromes are the best
characterized. However, despite numerous findings indicative of a
photoreceptor function of cryptochromes in Arabidopsis, the photo-
chemical reaction in blue-light signaling by cryptochromes is not
known and still the strongest evidence that Arabidopsis crypto-
chromes are blue-light receptors is their high degree of similarity to
photolyase (1, 2, 12).
Mammalian Cryptochromes
Discovery of Mammalian Cryptochromes—Based on exhaustive
biochemical data, it has been concluded that humans and other
placental mammals do not have photolyase (20). Therefore, the
report of a photolyase ortholog as an expressed sequence tag in the
human genome data base in 1995 (21) was unexpected and led to a
re-evaluation of the previous conclusion. Hsu et al. (22) found that
neither this protein nor a second ortholog they subsequently dis-
covered had photolyase activity and suggested that these proteins
must therefore perform other blue-light-dependent functions in
human cells and named them human cryptochrome 1 and crypto-
chrome 2 (hCRY1 and hCRY2). Taking into account the informa-
* This minireview will be reprinted in the 2004 Minireview Compendium,
which will be available in January, 2005. This work was supported by
National Institutes of Health Grant GM31082.
‡ To whom correspondence should be addressed. Tel.: 919-962-0115; Fax:
919-843-8627; E-mail: Aziz_Sancar@med.unc.edu.
1 The abbreviations used are: MTHF, methenyltetrahydrofolate; SCN,
suprachiasmatic nuclei.
Minireview
THE JOURNAL OF BIOLOGICAL CHEMISTRY
Vol. 279, No. 33, Issue of August 13, pp. 34079–34082, 2004
© 2004 by The American Society for Biochemistry and Molecular Biology, Inc.
Printed in U.S.A.
This paper is available on line at http://www.jbc.org 34079
This is an Open Access article under the CC BY license.
tion available on circadian photoreception at the time, it was pro-
posed that these proteins may function as circadian photoreceptors
(22).
In mice and humans, the outer (back) retina that contains rods
and cones is required for vision but not for entrainment of the
circadian clock. The inner (front) retina contains the ganglion cells,
the axons of which make up the optic nerve, and is sufficient to
entrain the circadian clock in the absence of the outer retina
(23–25). For this reason, humans and mice that become blind
because of retinal degeneration diseases that destroy the outer
retina can still synchronize their circadian clock to the daily light-
dark cycles (23, 26). Indeed, even the brain centers for vision and
circadian photoreception are separate (27, 28). The visual center is
located in the cortex whereas the circadian center is located in the
midbrain in two clusters of neurons above the optic chiasma called
the suprachiasmatic nuclei (SCN).
To test the hypothesis that cryptochromes function as circadian
photoreceptors, the expression pattern of Cry1 and Cry2 was ana-
lyzed. Cryptochromes were found to be expressed in all tissues;
however, expression was high in the retina and restricted to the
inner retina in both mice and humans (29–31). In the brain, mCry1
was highly expressed in the SCN, and expression exhibited a daily
oscillation, peaking at about 2:00 p.m. and reaching its nadir at
around 2:00 a.m. (29, 30). Thus, it appeared that cryptochrome was
expressed in the appropriate places for setting the clock and for
running it and gave credence not only to the hypothesis that cryp-
tochrome is a circadian photoreceptor but also raised the possibility
that cryptochrome is a component of the molecular clock (29).
Subsequently, cryptochromes were found in Drosophila and all
other insects tested as well as Xenopus and all other vertebrate
animals whose genomes have been sequenced (3–5). The most
extensive studies on animal cryptochromes have been carried out
with the mammalian and Drosophila cryptochromes. Below, our
current understanding of the mammalian cryptochrome will be
summarized and where necessary reference will be made to the
single Drosophila cryptochrome.
Biochemical Properties—Both human cryptochromes have been
purified from HeLa cells expressing the Cry genes ectopically (32)
and from E. coli as recombinant proteins (22). Proteins isolated
from both sources contain FAD and a pterin, presumably in the
form of MTHF. However, both cofactors are at grossly substoichio-
metric levels relative to the apoenzyme precluding extensive char-
acterization of their biophysical properties, including the redox
status of the flavin in the native enzyme. The hCRY1 and hCRY2
purified from E. coli exhibit a near-UV absorption peak at 420 nm
(22). The Drosophila cryptochrome exhibits properties similar to
those of human cryptochromes with a 420 nm near-UV absorption
peak and 1–5% cofactor content (4, 5).
At present, there is no crystal structure of any animal crypto-
chrome. Molecular modeling of the hCRY2 photolyase homology
region reveals a photolyase-like structure including the positively
charged DNA-binding groove (Fig. 1) (32). Both hCRY1 and hCRY2
bind with moderate affinity to DNA and with higher affinity to UV
light-damaged DNA but have no repair activity (32). The DNA
binding activity of cryptochrome might be an evolutionary relic of
its common ancestry with photolyase. As in the case of AtCry1 (33,
34), it has been reported that hCRY1 has an autophosphorylating
kinase activity; however, this activity is not light-dependent (33)
and its relevance to a putative cryptochrome photocycle is un-
known. In contrast to these biochemical activities of obscure sig-
nificance, human cryptochromes interact strongly with several
“clock proteins” to generate a transcriptional feedback loop called
the molecular clock, summarized below (27, 28).
Function of Mammalian Cryptochromes
Clock Function—The first direct evidence that cryptochrome
plays a role in the circadian clock came from the analysis of mice in
which the Cry2 gene was knocked out; wild type mice in constant
darkness exhibit a circadian rhythm of behavior with an intrinsic
period of 23.7 h. The Cry2/ mice exhibited a period about 1 h
longer than wild type mice (Fig. 3) (35). These data led to the
conclusion that Cry2, in addition to any putative photoreceptor
function, must have a light-independent role in the maintenance of
FIG. 1. Structures of photolyase and cryptochrome. Left, crystal
structure of E. coli photolyase (6); right, the computer-generated struc-
ture of human CRY2 (32). The C-terminal 106 amino acids of CRY2 are
not shown. Yellow, FAD; green, MTHF.
FIG. 2. Photolyase reaction mecha-
nism. The enzyme contacts the DNA back-
bone of the damaged strand and thermally
flips out the cyclobutane dimer from the
duplex into the active site cavity; the dimer
is split photochemically. The figure shows
the steps in the photochemical reaction.
The MTHF photoantenna absorbs a photon
and transfers the excitation energy to
FADH, which in turn transfers an elec-
tron to PyrPyr; the resulting dimer rad-
ical splits to two normal bases concomitant
with back electron transfer to restore the
flavin neutral radical to the catalytically
competent FADH form (2). Following re-
pair, the dinucleotide flips out of the en-
zyme and into the DNA, and the enzyme
dissociates from repaired DNA.
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the normal rhythm (35). This conclusion was strengthened and
extended by the analysis of mice lacking Cry1 or both Cry1 and
Cry2 (36, 37); Cry1/ mice have a period 1 h shorter than wild
type mice and, most strikingly, Cry1/; Cry2/ animals are
arrhythmic (Fig. 3). The cause of the drastic effect of the loss of
cryptochromes became apparent when the molecular basis of the
mammalian circadian rhythm was elucidated (see Refs. 27 and 28).
The molecular clock is generated by an autoregulatory transcrip-
tional loop with 24-h periodicity (Fig. 4A) composed of several
integral clock proteins. The key proteins that make up the molec-
ular clock in mammals are Clock, Bmal1, Cry1, Cry2, Per1, and
Per2. In addition, other clock proteins including Per3, Tim, Rev/
Erb, and CKI make important contributions in the maintenance
of robust oscillatory amplitude (27, 28).
The core of the molecular clock machinery may be summarized
as follows (Fig. 4A). The Clock and Bmal1 proteins are transcrip-
tion factors that function as a heterodimer, binding E-box motifs in
the promoters of the Bmal1, Cry1, Cry2, Per1, and Per2 genes to
stimulate their transcription. The Cry and Per proteins make com-
binatorial heterodimers and enter the nucleus, disrupting the
Clock-Bmal1 complex and down-regulating the transcription of the
genes driven by this complex, including their own. The ensuing
decline in Cry and Per protein levels eventually leads to reactiva-
tion of the Clock-Bmal1-regulated promoters and reinitiation of the
cycle. The clock transcriptional loop (oscillatory) differs from steady
state negative feedback transcriptional loops (homeostatic) because
of the concerted activity of the post-translational modifications
(including phosphorylation of Per by CKI) (38) regulating proteolytic
degradation and nucleocytoplasmic shuttling of the clock proteins.
These events add a lag phase between the synthesis of the transcrip-
tional inhibitors and their availability to act on their target within
the nucleus, such that the time interval between the maximum
transcription of the negative regulators and their actions on the
target transcription factors within the nucleus is about 24 h.
The molecular clock is present in virtually all mammalian tis-
sues. The master circadian clock, located in the SCN, performs two
fundamental functions for the manifestation of macroscopic (phys-
iological and behavioral) rhythms (28). First, it receives the light
signal from the retina, which stimulates transcription of Per1 and
Per2 genes, thus resetting the phase of the rhythm. Second, the
master clock synchronizes the peripheral clocks through neural and
humoral communication so as to achieve rhythm at the organism
level. The circadian rhythm at the organism level is achieved by the
action of Clock-Bmal1 and other components of the molecular clock-
work on the transcription of effector clock-controlled genes, such as
those involved in melatonin and corticosteroid synthesis. Crypto-
chromes clearly play a central role in the inhibitory branch of the
autoregulatory transcriptional loop that makes up the clock (39). As
a consequence, elimination of both cryptochromes results in consti-
tutively elevated levels of Clock-Bmal1-controlled transcripts (37, 39)
and hence molecular and behavioral arrhythmicity.
Cryptochrome as a Circadian Photoreceptor—Ironically, even
though cryptochrome was introduced into the field of circadian
biology as a putative circadian photoreceptor in the mammalian
circadian clock (22, 29), it is now securely established as a key clock
protein, but its role as a mammalian blue-light photoreceptor is a
matter of considerable debate and is far from proven. In fact, one
widely held view is that cryptochrome functions as a circadian
photoreceptor in Drosophila but it has lost its photoreceptive func-
tion in mammals and has become just another “cog” in the wheel of
the molecular clock (40, 41). Some of the findings that have led to this
view will be discussed. First, in yeast two-hybrid assays it has been
found that Drosophila Cry binds to the clock protein dTim in a
light-dependent manner (42, 43), but the human cryptochromes bind
to human Per1, Per2, Clock, and Tim proteins independently of light
(44). Second, Drosophila lacking all opsins and cryptochrome are
circadian blind (45, 46), whereas mice lacking rods, cones, and cryp-
tochromes exhibit residual photoresponses (47). Finally, the clock in
Drosophila peripheral organs (that contain no opsins but express
cryptochrome) can be reset by light (48). In contrast, photoreception
through the eye is essential for resetting the clock in mammals even
though cryptochromes are expressed in all tissues (49, 50).
Perhaps of more relevance to cryptochrome’s putative photore-
ceptive role is the presence of a newly discovered opsin called
melanopsin in the mammalian inner retina with a clear role in
circadian photoreception (51). Melanopsin is expressed in a small
fraction (1%) of the mouse retinal ganglion cells that innervate
the SCN (retinohypothalamic tract) and brain regions involved in
other non-visual photoreceptive tasks such as pupillary light re-
FIG. 3. Effect of cryptochrome mutation on the circadian behavior
of mice (35, 37). The circadian behavior was assessed by measuring the
wheel running activity as a function of time of day. The rpm of the running
wheel is plotted on the y axis, and the time of day is plotted on the x axis. The
activity is plotted twice from the 2nd day on to make a comparison of
activities in successive days easier. The bar on top indicates the dark (closed
rectangle) and light (open rectangle) phases of day. These graphs (actograms)
show activity profiles of four mice for a 28-day period. At the day indicated
by arrows the animals were switched from a 12 h light:12 h dark (LD) cycle
into constant darkness (DD). Note that under LD, all four mice exhibit 12-h
activity and 12-h rest phases with a 24-h daily periodicity. In DD, the mice
exhibit activity/rest phases with periodicities () imposed by their intrinsic
clock (free running), and the mutants behave differently from the wild type.
A, wild type,   23.7 h; B, Cry1/,   22.7 h; C, Cry2/;   24.7 h; D,
Cry1/;Cry2/, arrhythmic.
FIG. 4. Dark and light functions of mammalian cryptochrome. A,
dark function. This is a simplified scheme for the mammalian circadian
clock. Clock and Bmal1 form a heterodimer that binds to the E-box sequences
of target genes and stimulates their transcription. Crys and Pers also make
heterodimers in the cytoplasm, translocate into the nucleus, and inhibit
Clock-Bmal1-activated transcription (27, 28). B, light function. The light
signal received by the opsins in rods and cones in the outer (back) retina is
transmitted to the visual cortex by the optic nerve (blue). The light signal
received by both the rods and cones in the outer retina and by the crypto-
chromes and melanopsin in the inner retina (front) is transmitted to the
master circadian clock, the SCN, by a specialized group of retinal ganglion
cells constituting the retinohypothalamic tract (red) (4, 5).
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sponse (52–54). Elimination of melanopsin by gene knockout causes
only a modest reduction in circadian photoresponse (55–57). How-
ever, genetic ablation of rods and cones and melanopsin eliminates
both visual and circadian phototransduction, and these mice are
completely insensitive to light (58, 59). This last finding has given
credence to the notion that classical opsins and melanopsin play
redundant roles in circadian photoreception and are necessary and
sufficient for all mammalian photoresponses. This model, however, is
inconsistent with several observations, listed below, indicating a
photoreceptive role of cryptochrome in mammals.
Genetic analysis of photoreceptor contribution is most quantita-
tively performed at the molecular level using gene induction in the
SCN in response to light given in the dark cycle of the animals.
Mice lacking Cry2, the predominant cryptochrome in the mouse
retina, have 2-fold reduced sensitivity for photoinduction of genes
in the SCN even in the presence of the visual photoreceptors (35),
and mice lacking both Cry1 and Cry2 exhibit 10–20-fold reduced
sensitivity (47). Most strikingly, mice of the rd/rd;Cry1/;
Cry2/ genotype, which have no classical opsins or crypto-
chromes but retain melanopsin, exhibit nearly 3000-fold reduction
in circadian photosensitivity (47, 60). In addition, the pupillary
responses of rodless and coneless mice lacking cryptochromes are
20-fold less sensitive to blue light than rodless and coneless mice
(24). Finally, severe depletion of ocular retinaldehyde, the cofactor
of all opsins, was achieved by maintaining mice on a vitamin A-free
diet; this causes visual blindness and a 10,000-fold reduction in
pupillary light response (61) relative to wild type mice but has only
a modest effect on retinohypothalamic phototransduction as meas-
ured by light induction of genes in the SCN (61, 62). Importantly,
when ocular retinaldehyde is depleted in cryptochromeless mice, in
the majority of animals there is no gene induction in SCN and no
behavioral rhythmicity under 12 h light:12 h dark cycles as meas-
ured by wheel running activity (61), again indicating a role for
cryptochrome in circadian photoreception.
At face value, the retinal depletion data show that cryptochrome
can mediate circadian photoreception in the eye in the absence of
functional opsins. However, this conclusion is at odds with the
finding that elimination of opsins by genetic ablation abolishes all
visual and non-visual photoresponses. Clearly, in the absence of
opsins, cryptochrome cannot generate an action potential for neu-
rotransmission from the retina to the SCN (58, 59). One way to
reconcile these seemingly contradictory data is to assume that,
independently of the classical opsins, cryptochromes and melanop-
sin work cooperatively to generate a robust retinohypothalamic
photosignal (Fig. 4B). At present, no specific models can be ad-
vanced on how this might occur because neither the photochemical
reaction carried out by cryptochrome nor the downstream signaling
events initiated by melanopsin are known. It is clear, however, that
none of the mammalian photopigments identified to date (rod and
cone opsins, melanopsin, or cryptochromes) are independently essen-
tial for circadian phototransduction. This conclusion, in turn, brings
into focus the most central question of cryptochrome research not just
for mammalian cryptochromes but for all cryptochromes in plants,
animals, and bacteria: what is the primary photochemical reaction
carried out by cryptochrome? Despite the wealth of genetic evidence
that cryptochrome is a photoreceptor in Arabidopsis, Drosophila, and
mice, until this question is answered there will always be reserva-
tions about whether cryptochrome is a photoreceptor or a molecule
downstream of the actual photoreceptor.
REFERENCES
1. Cashmore, A. R. (2003) Cell 114, 537–543
2. Sancar, A. (2003) Chem. Rev. 103, 2203–2238
3. Todo, T. (1999) Mutat. Res. 434, 79–87
4. Hall, J. C. (2000) Curr. Opin. Neurobiol. 10, 456–466
5. Sancar, A. (2000) Annu. Rev. Biochem. 69, 31–67
6. Park, H. W., Kim, S. T., Sancar, A., and Deisenhofer, J. (1995) Science 268,
1866–1872
7. Tamada, T., Kitadokoro, K., Higuchi, Y., Inaka, K., Yasui, A., deRuiter, P. E.,
Eker, A. P. M., and Miki, K. (1997) Nat. Struct. Biol. 11, 887–891
8. Husain, I., Griffith, J. D., and Sancar, A. (1988) Proc. Natl. Acad. Sci. U. S. A.
85, 2258–2262
9. Park, H. J., Zhang, K., Ren, Y., Nadji, S., Sinha, N., Taylor, J. S., and Kung, C.
(2002) Proc. Natl. Acad. Sci. U. S. A. 99, 15965–15970
10. Zhao, X., Liu, J., Hsu, D. S., Zhao, S., Taylor, J. S., and Sancar, A. (1997)
J. Biol. Chem. 272, 32580–32590
11. Hitomi, K., Nakamura, H., Kim, S. T., Mizukoshi, T., Ishikawa, T., Iwai S., and
Todo, T. (2001) J. Biol. Chem. 276, 10103–10109
12. Lin, C., and Shalitin, D. (2003) Annu. Rev. Plant Biol. 54, 469–496
13. Gressel, J. (1977) Photochem. Photobiol. 48, 11–20
14. Briggs, W. H., and Christie, J. M. (2002) Trends Plant Sci. 7, 204–210
15. Imaizumi, T., Tran, H. G., Swartz, T. E., Briggs, W. R., and Kay, S. A. (2003)
Nature 426, 302–306
16. Ahmad, M., and Cashmore, A. R. (1993) Nature 366, 162–166
17. Lin, C., Robertson, D. E., Ahmad, M., Raibekas, A. A., Jorns, M. S., Sutton,
P. L., and Cashmore, A. R. (1995) Science 269, 968–970
18. Todo, T., Ryo, H., Yamamoto, K., Toh, H., Inui, T., Ayaki, H., Nomura, T., and
Ikenaga, M. (1996) Science 272, 109–112
19. Malhotra, K., Kim, S. T., Batschauer, A., Dawut, L., and Sancar, A. (1995)
Biochemistry 34, 6892–6899
20. Li, Y. F., Kim, S. T., and Sancar, A. (1993) Proc. Natl. Acad. Sci. U. S. A. 90,
4389–4393
21. Adams, M. D., Kerlavage, A. R., Fleischmann, R. D., Fulder, R. A., Bult, C. J.
et al. (1995) Nature 377, 3–174
22. Hsu, D. S., Zhao, X., Zhao, S., Kazantsev, A., Wang, R. P., Todo, T., Wei, Y. F.,
and Sancar, A. (1996) Biochemistry 35, 13871–13877
23. Ebihara, S., and Tsuji, K. (1980) Physiol. Behav. 24, 523–527
24. Van Gelder, R. N., Wee, R., Lee, J. A., and Tu, D. C. (2003) Science 299, 222
25. Van Gelder, R. N. (2003) Trends Neurosci. 26, 458–461
26. Czeisler, C. A., Shanahan, T. L., Klerman, E. B., Martens, H., Brotman, D. J.,
Emens, J. S., Klein, T., and Rizzo, J. F. (1995) N. Engl. J. Med. 332, 6–11
27. Young, M. W., and Kay, S. A. (2001) Nat. Rev. Genet. 2, 702–715
28. Reppert, S. M., and Weaver, D. R. (2002) Nature 418, 935–941
29. Miyamoto, Y., and Sancar, A. (1998) Proc. Natl. Acad. Sci. U. S. A. 95,
6097–6102
30. Miyamoto, Y., and Sancar, A. (1999) Mol. Brain Res. 71, 248–253
31. Thompson, C. L., Bowes Rickman, C., Shaw, S. J., Ebright, J. N., Kelly, U.,
Sancar, A., and Rickman, D. W. (2003) Investig. Ophthalmol. Vis. Sci. 44,
4515–4521
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